United StatesCarbamazepine Tablets, USP 200 mg in 1000‑count prescription bottles (NDC 51672‑4005‑3), Lot AD94033, exp. 5/31/2028, distributed by Taro Pharmaceuticals USA and recalled by Sun Pharmaceutical Industries. The product was recalled for CGMP deviations after black spots were found on tablets caused by burnt excipient during manufacturing.
What's being recalled
Carbamazepine Tablets, USP, 200mg, 1000 count bottles, Rx only, Manufactured by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Distributed by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC 51672-4005-3.
Recalling firm: Sun Pharmaceutical Industries Inc, Princeton, NJ, United States.
How to identify it
Lot # AD94033, Exp Date: 5/31/2028.
The hazard
CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
US Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)